INTERNATIONAL PATENT: ELEVA GMBH FILES APPLICATION FOR "SIALYLATED HUMAN FACTOR H PROTEIN FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA"

GENEVA, Aug. 11 -- ELEVA GMBH (Hans-Bunte-Str. 1979108 Freiburg im Breisgau) filed a patent application (PCT/EP2025/052707) for "SIALYLATED HUMAN FACTOR H PROTEIN FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA" on Feb 03, 2025. With publication no. WO/2025/163202, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SIEVERT, Christian (c/o Eleva GmbHHans-Bunte-Str. 1979108 Freiburg im Breisgau), KRIEGHOFF, Nicola (c/o Eleva GmbHHans-Bunte-Str. 1979108 Freiburg im Breisgau), FODE, Benjamin (c/o Eleva GmbHHans-Bunte-Str. 1...